The Improved Sock is made of yarns knitted to include a foot portion and a calf portion, with graduated compression on an individual's foot from the foot to the calf. The yarns can include wool and alpaca fibers. A substantial proportion of wool and/or alpaca are on the inside of the sock so as to be in direct contact with the skin and wound. The Improved Sock provides absorption and wicking of inflammatory mediators, bacteria and biofilm and necrotic exudate from the foot and leg. The Improved Sock has AgNP shapes electrostatically bonded to the yarn. At least 30% of the mass of the AgNP shapes attached to the fibers have a shape selected from the group including truncated triangular plates (a triangle with the corners rounded off), triangular prisms, and/or discs. The Improved Sock functions as a unique wound dressing with the sock in direct contact with the wound.

Wounds dressings, systems, and methods are presented that involve using a patient's body heat to enhance liquid removal from the wound dressing through a high-moisture-vapor-transmission-rate drape. Additional heat sources or devices, such as nano-antennas or electrical heating elements, may be added or used separately to enhance the removal liquid from the wound dressing. Other dressings, systems, and methods are presented herein.

The invention relates to a flat wound care article having an essentially polygonal or ellipsoid base surface and at least one recess arranged on one side.

The present invention relates to hemostatic scaffold compositions and the method of preparation thereof. In present invention, hemostatic scaffold compositions for wound care and dental care, uses chitosan and tranexamic acid.

The invention provides a wound dressing made by an ex vivo formed combination of fibrinogen and/or fibrin containing-liquid formulation and an oxidized cellulose (OC) backing; and use thereof.

Proposed are a method of manufacturing a hemostatic medical material that has excellent biosafety and can be applied to various situations by controlling the decomposition rate as necessary, and a medical material manufactured thereby. The method includes pretreating a natural cellulose substrate by adjusting the pH of the substrate, causing the hemostatic agent to be adsorbed on the pretreated substrate, drying the substrate with the hemostatic agent adsorbed thereon, primarily modifying the dried substrate using monochloroacetic acid (MCA), secondarily modifying the primarily modified substrate using an organic acid aqueous solution, washing the secondarily modified substrate, and post treating the substrate by adjusting the pH of the washed substrate.

A toroidal compression bandage includes: a soft fibrous material, defined by an absorbency of a predetermined amount; a compression bandage form comprised of soft fibrous absorbent material in a rolled, wrapped form and of a shape defined by a circle revolved in three-dimensional space about a circular axis coplanar with the circle, wherein the axis of revolution does not touch the rotated circle, to define a torus ring compression bandage; an aperture defined within a center area of the torus ring compression bandage as it is formed, the aperture having a predetermined diameter and configured for placement directly over a trauma wound to avoid contact with the trauma wound; and a compression surface defined on an underside of the torus ring compression bandage, the compression surface configured for circumferential placement around the trauma wound to avoid direct contact of the trauma wound, and for absorption placement around the trauma wound.

The invention relates to a wound dressing which is particularly suited for therapeutically dressing wounds. Said wound dressing comprises at least one air permeable layer having a porous and/or foam-based structure, particularly in the form of a solid foam (foam layer), and at least one sorbent in the form of activated carbon.

Wounds dressings, systems, and methods are presented that involve using a patient's body heat to enhance liquid removal from the wound dressing through a high-moisture-vapor-transmission-rate drape. Additional heat sources or devices, such as nano-antennas or electrical heating elements, may be added or used separately to enhance the removal liquid from the wound dressing. Other dressings, systems, and methods are presented herein.

The present invention relates to the use of a shrinkable biopolymer fiber as sensor. In a first embodiment, the sensor allows to determine the authenticity of a product. In a second embodiment, the sensor allows to determine the presence of a solvent. Further, the present invention relates to a method for determining the authenticity of a product. Furthermore, the present invention relates to a method for determining the presence of a solvent. In addition, the present invention relates to the use of a shrinkable biopolymer fiber for shaping an object. Moreover, the present invention relates to a method for shaping an object. Moreover, the present invention relates to the use of a shrinkable biopolymer fiber as suture material or wound dressing.